Inflammatix, Inc.

Biotechnology ResearchCalifornia, United States51-200 Employees

Inflammatix is advancing emergency and critical care medicine by leveraging the body’s immune response to support timely, informed decision-making for patients with suspected acute infection or sepsis.

TriVerity™ is an FDA-cleared, rapid blood test that applies AI-driven analysis of immune mRNA expression to deliver three results in approximately 30 minutes: likelihood of bacterial infection, likelihood of viral infection, and risk of near-term clinical deterioration.

By reducing diagnostic uncertainty early in the patient encounter, TriVerity supports risk stratification and clinical assessment in the emergency department, helping clinicians better understand which patients may require closer monitoring or inpatient care and which patients may be appropriate for lower-acuity pathways.

Inflammatix translates immune response data into real-time clinical insights designed to support high-quality care delivery while aligning with health system priorities around operational efficiency, antimicrobial stewardship, and value-based performance.

Sign up for free to view info

Email Format Employee directory